Related Experiment Video
Updated: Nov 20, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Late Bacterial Endocarditis in an Intravenous Drug User With an Amplatzer Septal Occluder
Michael S La Sala1, Hajir Zohourian2, Joseph McKeown3
1College of Osteopathic Medicine, Nova Southeastern University, Davie, Florida 33328.
Insights
Late infective endocarditis, a rare complication of the Amplatzer Septal Occluder, occurred 14 years post-implantation in an intravenous drug user. Surgical intervention led to recovery, highlighting the need for ongoing surveillance in high-risk patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Device Technology
Background:
- Infective endocarditis in cardiac devices presents unique challenges, particularly late-onset cases.
- The Amplatzer Septal Occluder is commonly used for atrial septal defect closure, but late endocarditis is rare.
Observation:
- A case of late bacterial endocarditis in an Amplatzer Septal Occluder is presented.
- The patient was an intravenous drug user with methicillin-sensitive Staphylococcus aureus bacteremia, nearly 14 years after device implantation.
Findings:
- Successful treatment involved surgical excision and débridement of the vegetative mass.
- This surgical approach may be the first reported for this specific complication.
Implications:
- This case underscores the importance of considering late endocarditis in patients with septal occluder devices.
- Routine screening for high-risk individuals with these devices is recommended to detect early signs of infection.
Abstract:
Infective endocarditis of a fully endothelialized cardiac prosthesis, and especially the late presentation of endocarditis, challenges our current understanding of device-related complications. Late bacterial endocarditis associated with the Amplatzer Septal Occluder, a device frequently used to close atrial septal defects, has been documented only rarely. We report the case of an intravenous drug user who had late infective endocarditis associated with his Amplatzer Septal Occluder, secondary to methicillin-sensitive Staphylococcus aureus bacteremia nearly 14 years after device insertion. The patient recovered after surgical excision and débridement of the vegetative mass, which may be the first time that a surgical approach has been taken to treat this condition. This report corroborates the need for late screening of high-risk patients who have septal occluder devices.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis
Mitral Stenosis III: Medical Management
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

